Zidovudine prophylaxis after accidental exposure to HIV: The Italian experience

Vincenzo Puro, Giuseppe Ippolito, Elio Guzzanti, Irinus Serafin, Gabriella Pagano, Fredy Suter, Graziella Cristini, Claudio Arici, Gioacchino Angarano, Fabrizio Soscia, Alberto Vaglia, Lucio Bonazzi

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Objectives: To evaluate the use of zidovudine prophylaxis in HIV-exposed health-care workers (HCW) in Italy and to determine its short-term toxicity. Design: Longitudinal, open study with retrospective and prospective collection of data. Setting: All Italian clinical centres that care for HIV-infected patients and are licensed by the Ministry of Health to dispense zidovudine and 30 hospitals participating in the Italian Multicentre Study on Occupational Risk of HIV Infection. Study population: HCW and other individuals who accepted zidovudine prophylaxis after accidental exposure to HIV. Results: Data were collected for 224 HIV-exposed individuals until 30 June 1991. An increase in zidovudine prophylaxis was observed. All but 10 subjects received 1000-1250 mg zidovudine per day. Anaemia (five cases), neutropenia (one case) and an increase in serum alanine aminotransferase levels (two cases) were the only haematochemical side-effects observed; none of the subjects ceased prophylaxis because of side-effects. More than 50% of subjects had constitutional reactions; as a result, prophylaxis was stopped by 29 patients. These adverse effects began within 10 days of prophylaxis; all resolved after prophylaxis was stopped. No HIV-antibody seroconversions were observed after a mean follow-up of 8 months. Conclusions: Zidovudine prophylaxis has become a feature of the management of occupational exposures to HIV in health-care settings; short-term toxicity is mild, dose-related and reversible. Further studies are needed to assess the risk of long-term sequelae.

Original languageEnglish
Pages (from-to)963-969
Number of pages7
JournalAIDS (London, England)
Volume6
Issue number9
Publication statusPublished - Sep 1992

Fingerprint

Zidovudine
HIV
Delivery of Health Care
HIV Seropositivity
HIV Antibodies
Occupational Exposure
Neutropenia
Alanine Transaminase
Italy
Multicenter Studies
HIV Infections
Longitudinal Studies
Anemia
Health
Serum
Population

Keywords

  • HIV infection
  • Occupational exposures
  • Zidovudine prophylaxis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Puro, V., Ippolito, G., Guzzanti, E., Serafin, I., Pagano, G., Suter, F., ... Bonazzi, L. (1992). Zidovudine prophylaxis after accidental exposure to HIV: The Italian experience. AIDS (London, England), 6(9), 963-969.

Zidovudine prophylaxis after accidental exposure to HIV : The Italian experience. / Puro, Vincenzo; Ippolito, Giuseppe; Guzzanti, Elio; Serafin, Irinus; Pagano, Gabriella; Suter, Fredy; Cristini, Graziella; Arici, Claudio; Angarano, Gioacchino; Soscia, Fabrizio; Vaglia, Alberto; Bonazzi, Lucio.

In: AIDS (London, England), Vol. 6, No. 9, 09.1992, p. 963-969.

Research output: Contribution to journalArticle

Puro, V, Ippolito, G, Guzzanti, E, Serafin, I, Pagano, G, Suter, F, Cristini, G, Arici, C, Angarano, G, Soscia, F, Vaglia, A & Bonazzi, L 1992, 'Zidovudine prophylaxis after accidental exposure to HIV: The Italian experience', AIDS (London, England), vol. 6, no. 9, pp. 963-969.
Puro, Vincenzo ; Ippolito, Giuseppe ; Guzzanti, Elio ; Serafin, Irinus ; Pagano, Gabriella ; Suter, Fredy ; Cristini, Graziella ; Arici, Claudio ; Angarano, Gioacchino ; Soscia, Fabrizio ; Vaglia, Alberto ; Bonazzi, Lucio. / Zidovudine prophylaxis after accidental exposure to HIV : The Italian experience. In: AIDS (London, England). 1992 ; Vol. 6, No. 9. pp. 963-969.
@article{86e72d1fa3d24bd5af7db4f06420f7a5,
title = "Zidovudine prophylaxis after accidental exposure to HIV: The Italian experience",
abstract = "Objectives: To evaluate the use of zidovudine prophylaxis in HIV-exposed health-care workers (HCW) in Italy and to determine its short-term toxicity. Design: Longitudinal, open study with retrospective and prospective collection of data. Setting: All Italian clinical centres that care for HIV-infected patients and are licensed by the Ministry of Health to dispense zidovudine and 30 hospitals participating in the Italian Multicentre Study on Occupational Risk of HIV Infection. Study population: HCW and other individuals who accepted zidovudine prophylaxis after accidental exposure to HIV. Results: Data were collected for 224 HIV-exposed individuals until 30 June 1991. An increase in zidovudine prophylaxis was observed. All but 10 subjects received 1000-1250 mg zidovudine per day. Anaemia (five cases), neutropenia (one case) and an increase in serum alanine aminotransferase levels (two cases) were the only haematochemical side-effects observed; none of the subjects ceased prophylaxis because of side-effects. More than 50{\%} of subjects had constitutional reactions; as a result, prophylaxis was stopped by 29 patients. These adverse effects began within 10 days of prophylaxis; all resolved after prophylaxis was stopped. No HIV-antibody seroconversions were observed after a mean follow-up of 8 months. Conclusions: Zidovudine prophylaxis has become a feature of the management of occupational exposures to HIV in health-care settings; short-term toxicity is mild, dose-related and reversible. Further studies are needed to assess the risk of long-term sequelae.",
keywords = "HIV infection, Occupational exposures, Zidovudine prophylaxis",
author = "Vincenzo Puro and Giuseppe Ippolito and Elio Guzzanti and Irinus Serafin and Gabriella Pagano and Fredy Suter and Graziella Cristini and Claudio Arici and Gioacchino Angarano and Fabrizio Soscia and Alberto Vaglia and Lucio Bonazzi",
year = "1992",
month = "9",
language = "English",
volume = "6",
pages = "963--969",
journal = "AIDS",
issn = "0269-9370",
publisher = "NLM (Medline)",
number = "9",

}

TY - JOUR

T1 - Zidovudine prophylaxis after accidental exposure to HIV

T2 - The Italian experience

AU - Puro, Vincenzo

AU - Ippolito, Giuseppe

AU - Guzzanti, Elio

AU - Serafin, Irinus

AU - Pagano, Gabriella

AU - Suter, Fredy

AU - Cristini, Graziella

AU - Arici, Claudio

AU - Angarano, Gioacchino

AU - Soscia, Fabrizio

AU - Vaglia, Alberto

AU - Bonazzi, Lucio

PY - 1992/9

Y1 - 1992/9

N2 - Objectives: To evaluate the use of zidovudine prophylaxis in HIV-exposed health-care workers (HCW) in Italy and to determine its short-term toxicity. Design: Longitudinal, open study with retrospective and prospective collection of data. Setting: All Italian clinical centres that care for HIV-infected patients and are licensed by the Ministry of Health to dispense zidovudine and 30 hospitals participating in the Italian Multicentre Study on Occupational Risk of HIV Infection. Study population: HCW and other individuals who accepted zidovudine prophylaxis after accidental exposure to HIV. Results: Data were collected for 224 HIV-exposed individuals until 30 June 1991. An increase in zidovudine prophylaxis was observed. All but 10 subjects received 1000-1250 mg zidovudine per day. Anaemia (five cases), neutropenia (one case) and an increase in serum alanine aminotransferase levels (two cases) were the only haematochemical side-effects observed; none of the subjects ceased prophylaxis because of side-effects. More than 50% of subjects had constitutional reactions; as a result, prophylaxis was stopped by 29 patients. These adverse effects began within 10 days of prophylaxis; all resolved after prophylaxis was stopped. No HIV-antibody seroconversions were observed after a mean follow-up of 8 months. Conclusions: Zidovudine prophylaxis has become a feature of the management of occupational exposures to HIV in health-care settings; short-term toxicity is mild, dose-related and reversible. Further studies are needed to assess the risk of long-term sequelae.

AB - Objectives: To evaluate the use of zidovudine prophylaxis in HIV-exposed health-care workers (HCW) in Italy and to determine its short-term toxicity. Design: Longitudinal, open study with retrospective and prospective collection of data. Setting: All Italian clinical centres that care for HIV-infected patients and are licensed by the Ministry of Health to dispense zidovudine and 30 hospitals participating in the Italian Multicentre Study on Occupational Risk of HIV Infection. Study population: HCW and other individuals who accepted zidovudine prophylaxis after accidental exposure to HIV. Results: Data were collected for 224 HIV-exposed individuals until 30 June 1991. An increase in zidovudine prophylaxis was observed. All but 10 subjects received 1000-1250 mg zidovudine per day. Anaemia (five cases), neutropenia (one case) and an increase in serum alanine aminotransferase levels (two cases) were the only haematochemical side-effects observed; none of the subjects ceased prophylaxis because of side-effects. More than 50% of subjects had constitutional reactions; as a result, prophylaxis was stopped by 29 patients. These adverse effects began within 10 days of prophylaxis; all resolved after prophylaxis was stopped. No HIV-antibody seroconversions were observed after a mean follow-up of 8 months. Conclusions: Zidovudine prophylaxis has become a feature of the management of occupational exposures to HIV in health-care settings; short-term toxicity is mild, dose-related and reversible. Further studies are needed to assess the risk of long-term sequelae.

KW - HIV infection

KW - Occupational exposures

KW - Zidovudine prophylaxis

UR - http://www.scopus.com/inward/record.url?scp=0026730950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026730950&partnerID=8YFLogxK

M3 - Article

C2 - 1388909

AN - SCOPUS:0026730950

VL - 6

SP - 963

EP - 969

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 9

ER -